Literature DB >> 17891139

Inhibition of Crm1-p53 interaction and nuclear export of p53 by poly(ADP-ribosyl)ation.

Masayuki Kanai1, Kazuhiko Hanashiro, Song-Hee Kim, Shuji Hanai, A Hamid Boulares, Masanao Miwa, Kenji Fukasawa.   

Abstract

Poly(ADP-ribose) polymerase 1 (PARP-1) and p53 are two key proteins in the DNA-damage response. Although PARP-1 is known to poly(ADP-ribosyl)ate p53, the role of this modification remains elusive. Here, we identify the major poly(ADP-ribosyl)ated sites of p53 by PARP-1 and find that PARP-1-mediated poly(ADP-ribosyl)ation blocks the interaction between p53 and the nuclear export receptor Crm1, resulting in nuclear accumulation of p53. These findings molecularly link PARP-1 and p53 in the DNA-damage response, providing the mechanism for how p53 accumulates in the nucleus in response to DNA damage. PARP-1 becomes super-activated by binding to damaged DNA, which in turn poly(ADP-ribosyl)ates p53. The nuclear export machinery is unable to target poly(ADP-ribosyl)ated p53, promoting accumulation of p53 in the nucleus where p53 exerts its transactivational function.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17891139     DOI: 10.1038/ncb1638

Source DB:  PubMed          Journal:  Nat Cell Biol        ISSN: 1465-7392            Impact factor:   28.824


  96 in total

1.  Identification of poly (ADP-ribose) polymerase-1 (PARP-1) as a novel Kruppel-like factor 8-interacting and -regulating protein.

Authors:  Heng Lu; Xianhui Wang; Tianshu Li; Alison M Urvalek; Lin Yu; Jieli Li; Jinghua Zhu; Qishan Lin; Xu Peng; Jihe Zhao
Journal:  J Biol Chem       Date:  2011-04-25       Impact factor: 5.157

2.  Nuclear translocation of p65 NF-kappaB is sufficient for VCAM-1, but not ICAM-1, expression in TNF-stimulated smooth muscle cells: Differential requirement for PARP-1 expression and interaction.

Authors:  Mourad Zerfaoui; Yasuhiro Suzuki; Amarjit S Naura; Chetan P Hans; Charles Nichols; A Hamid Boulares
Journal:  Cell Signal       Date:  2007-10-12       Impact factor: 4.315

3.  XPO1 Inhibition using Selinexor Synergizes with Chemotherapy in Acute Myeloid Leukemia by Targeting DNA Repair and Restoring Topoisomerase IIα to the Nucleus.

Authors:  Parvathi Ranganathan; Trinayan Kashyap; Xueyan Yu; Xiaomei Meng; Tzung-Huei Lai; Betina McNeil; Bhavana Bhatnagar; Sharon Shacham; Michael Kauffman; Adrienne M Dorrance; William Blum; Deepa Sampath; Yosef Landesman; Ramiro Garzon
Journal:  Clin Cancer Res       Date:  2016-06-29       Impact factor: 12.531

Review 4.  Next-generation sequencing reveals the secrets of the chronic lymphocytic leukemia genome.

Authors:  Andrew J Ramsay; Alejandra Martínez-Trillos; Pedro Jares; David Rodríguez; Agnieszka Kwarciak; Víctor Quesada
Journal:  Clin Transl Oncol       Date:  2012-08-22       Impact factor: 3.405

Review 5.  p53 regulation upon genotoxic stress: intricacies and complexities.

Authors:  Rajni Kumari; Saishruti Kohli; Sanjeev Das
Journal:  Mol Cell Oncol       Date:  2014-12-23

6.  PARP1 interacts with HMGB1 and promotes its nuclear export in pathological myocardial hypertrophy.

Authors:  Qian Li; Zhuo-Ming Li; Shu-Ya Sun; Lu-Ping Wang; Pan-Xia Wang; Zhen Guo; Han-Wei Yang; Jian-Tao Ye; Jing Lu; Pei-Qing Liu
Journal:  Acta Pharmacol Sin       Date:  2018-07-20       Impact factor: 6.150

7.  CRM1 inhibition induces tumor cell cytotoxicity and impairs osteoclastogenesis in multiple myeloma: molecular mechanisms and therapeutic implications.

Authors:  Y-T Tai; Y Landesman; C Acharya; Y Calle; M Y Zhong; M Cea; D Tannenbaum; A Cagnetta; M Reagan; A A Munshi; W Senapedis; J R Saint-Martin; T Kashyap; S Shacham; M Kauffman; Y Gu; L Wu; I Ghobrial; F Zhan; A L Kung; S A Schey; P Richardson; N C Munshi; K C Anderson
Journal:  Leukemia       Date:  2013-04-16       Impact factor: 11.528

Review 8.  Oncogenic role of p21 in hepatocarcinogenesis suggests a new treatment strategy.

Authors:  Shogo Ohkoshi; Masahiko Yano; Yasunobu Matsuda
Journal:  World J Gastroenterol       Date:  2015-11-14       Impact factor: 5.742

9.  CRM1 blockade by selective inhibitors of nuclear export attenuates kidney cancer growth.

Authors:  Hiromi Inoue; Michael Kauffman; Sharon Shacham; Yosef Landesman; Joy Yang; Christopher P Evans; Robert H Weiss
Journal:  J Urol       Date:  2012-10-16       Impact factor: 7.450

10.  Poly(ADP-ribose) polymerase-1-induced NAD(+) depletion promotes nuclear factor-κB transcriptional activity by preventing p65 de-acetylation.

Authors:  Tiina M Kauppinen; Li Gan; Raymond A Swanson
Journal:  Biochim Biophys Acta       Date:  2013-04-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.